Approximately 28 million people living in the United States suffer from some degree of hearing loss. It is the most frequently occurring birth defect—about three of every 1,000 babies are born with hearing loss.

Approximately 28 million people living in the United States suffer from some degree of hearing loss. It is the most frequently occurring birth defect—about three of every 1,000 babies are born with hearing loss.
Part 1 of 2 articles
PHOENIX-Cysts on vocal folds can be tricky lesions to tackle-more challenging than many otolargyngologists might think, a panel of experts said here.
Part 2 of 2 articles
PHILADELPHIA-Surgeons are faced with many options for approaching diseases of the sinus; the right approach is not always clear-cut. Five experts reviewed several approaches at Rhinology World held here recently, with some favoring a more aggressive approach, some preferring to be less aggressive, and others highlighting new technology.
PHOENIX-Just how useful are PET or PET-CT in identifying residual occult nodal disease in patients with head and neck cancer? Two presentations at the 2009 Combined Otolaryngology Spring Meeting addressed this topic.
PHOENIX-As James D. Smith, MD, took his place behind the lectern to prepare to speak about what America’s role should be in the instruction of physicians in underprivileged and disease-stricken countries, a question was posed on the screen next to him: Do we have a responsibility to help?
PHOENIX-Performing salvage surgery after chemoradiation or radiation treatment for laryngeal cancer patients, rather than just performing primary surgery right away, appears to lead to more complications with patients’ tracheoesophageal voice prostheses, according to a retrospective study reported by researchers here.
Laryngeal biopsies are being performed more commonly as in-office procedure. ENT Today asked two otolaryngologists about the ins and outs of performing the procedure in-office.
ORLANDO-Concurrent chemoradiotherapy (CRT) is considered standard treatment for unresectable advanced head and neck cancer. A new study presented at the 2009 meeting of the American Society of Clinical Oncology (ASCO) suggests that induction chemotherapy (IC) delivered before CRT significantly improved time to treatment failure (TTF) compared with standard upfront CRT alone in this setting.
PHOENIX-Eosinophilic esophagitis is a serious, growing problem that is little understood by many otolaryngologists, according to panelists discussing the disease. Some doctors who specialize in swallowing disorders acknowledged that they were not even aware of the problem, let alone well versed in diagnosing and treating the illness, according to results of a survey completed by 80 members of the American Broncho-Esophagological Association (ABEA).